SEARCH:   Advanced

Prepublished online as a Blood First Edition Paper on September 12, 2002; DOI 10.1182/blood-2002-07-1975. This Article Full Text (PDF) All Versions of this Article: 2002-07-1975v1 101/3/791    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Chui, D. H. K. Articles by Chan, V. Search for Related Content PubMed PubMed Citation Articles by Chui, D. H. K. Articles by Chan, V. Related Collections Red Cells Review Articles Clinical Trials and Observations Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, 1 February 2003, Vol. 101, No. 3, pp. 791-800 REVIEW ARTICLE Hemoglobin H disease: not necessarily a benign disorder David H. K. Chui, Suthat Fucharoen, and Vivian Chan From the Department of Pathology and Molecular Medicine, McMaster University Faculty of Health Sciences, Hamilton, ON, Canada; Thalassemia Research Center, Institute of Science and Technology for Research and Development, Mahidol University, Salaya Campus, Puttamonthon, Nakornpathom, Thailand; and University Department of Medicine, University of Hong Kong and Queen Mary Hospital, Hong Kong, China.     Introduction Top Introduction -Thalassemia mutations Genotypes of Hb H... Pathophysiology Clinical and laboratory... Alpha-thalassemia/mental... Acquired Hb H disease... Diagnosis Treatment Genetic counseling Summary References Introduction The hemoglobin molecule is a tetramer consisting of 2 pairs of globin chains, each of which contains a heme group. During fetal development, the major hemoglobin is Hb F (22). In a normal adult, the major hemoglobin is Hb A (22). The -globin gene cluster is located on chromosome 16pter-p13.3 and is made up of one embryonic -globin and 2 -globin genes in tandem (in cis): 5'-2-2-1-3'.1 Because each person has 2 chromosomes 16, most people have 4 -globin genes. The -globin gene cluster, 5'--G-A---3' is located on chromosome 11p15.5. -Thalassemia is caused by mutations or deletions affecting either one or more -globin genes, leading to decreased or absent -globin chain production from the affected gene(s).2 The deletion or inactivation of only one -globin gene usually results in insignificant hematologic findings. When 2 -globin genes are deleted or inactivated, either both on the same chromosome 16 (in cis) or one on each of the 2 chromosomes 16 (in trans), the affected person is well but has borderline anemia, as well as microcytic and hypochromic red blood cells.3 When 3 -globin genes become inactive because of deletions with or without concomitant nondeletional mutations, the affected individual would have only one functional -globin gene. These people usually have moderate anemia and marked microcytosis and hypochromia. In affected adults, there is an excess of -globin chains within their erythrocytes that will form 4 tetramer, also known as Hb H. This hereditary disorder is known as Hb H disease.3 The most severe form of -thalassemia is that of fetuses lacking all -globin genes. Some succumb early in gestation. Most develop hydrops fetalis syndrome and die in utero during the second or the third trimester of pregnancy, or shortly after birth.3-5     -Thalassemia mutations Top Introduction -Thalassemia mutations Genotypes of Hb H... Pathophysiology Clinical and laboratory... Alpha-thalassemia/mental... Acquired Hb H disease... Diagnosis Treatment Genetic counseling Summary References Deletional mutations Deletions removing one -globin gene, such as the rightward (-3.7) or leftward (-4.2) single -globin gene deletions, are results of misalignment crossovers during meiosis (Figure 1). These deletions are very common and are found in 30% of African Americans and up to 60% to 80% of people living in parts of Saudi Arabia, India, Thailand, Papua New Guinea, and Melanesia.6,7 These single -globin gene deletions and other point mutations involving a single -globin gene (see "Nondeletional mutations") are known as the +-thalassemia mutations.2 View larger version (13K): [in this window] [in a new window]   Figure 1. Common deletions in the --globin gene cluster. The 3 red boxes represent the 3 active globin genes, the one embryonic 2-globin gene, and the 2- and 1-globin genes. They span approximately 26 Kb in length from 2 to 1 globin genes. The blue lines represent the common -thalassemia deletions. Figure adapted with permission from Cambridge University Press2 and Blood.5 There are more than 20 known natural deletions that remove both -globin genes on the same chromosome 16 (in cis) or the complete --globin gene cluster, and they are known as the 0-thalassemia mutations.2 Some deletions might measure 100 to 300 kb or more in length. In addition, there are rare deletions that silence -globin gene expression by removing the HS-40 regulatory sequences upstream of the --globin gene cluster.2 The (--SEA) type of 0-thalassemia deletion of approximately 19.3 kb in length removing both -globin genes in cis but sparing the embryonic -globin gene is common in Southeast Asia. It is found in 14% of people living in Northern Thailand, for example.5 This mutation is the most common cause for Hb H disease (Table 1) and hydrops fetalis syndrome in that part of the world. In addition, the (--FIL), (--MED), and ()20.5 deletions are relatively common in the Philippines and in the Mediterranean region, respectively (Figure 1).                                View this table: [in this window] [in a new window]   Table 1. -Globin genotypes in 319 patients with Hb H disease from California, Hong Kong, and Ontario31,33,41 Nondeletional mutations In contrast to -thalassemia, nondeletional +-thalassemia mutations are relatively uncommon. There is an inherent difficulty in deciphering these mutations, because nucleotide sequencing of the -globin genes with their high GC content is not an easy task. In recent years, increasing numbers of nondeletional +-thalassemia mutations have been described. More than 30 of these mutations are tabulated in the human globin gene mutation database on the World Wide Web (http://globin.cse.psu.edu). The 2-globin gene normally accounts for 2 to 3 times more -globin mRNA and -globin chain production than the 1-globin gene.8 Therefore, -thalassemia point mutations of the 2-globin gene generally cause more severe anemia than the same mutations involving the 1-globin gene. Most of these mutations affect the transcriptional or translational processes of -globin chain production. Others, notably Hb Constant Spring (2 codon 142 TAA>CAA or TerGln) lead to markedly decreased and abnormally elongated -globin chains.2 Recently, it was reported that as many as 15% of patients previously thought to be carriers of Hb Constant Spring based on hemoglobin analysis were in fact carriers of Hb Pakse (2 codon 142 TAA>TAT or TerTyr).9,10,141 Other mutations produce highly unstable -globin chains or hemoglobins, such as Hb Agrinio (2 codon 29 CTG>CCG or LeuPro), Hb Suan-Dok (2 codon 109 CTG>CGG or LeuArg), Hb Quong Sze (2 codon 125 CTG>CCG or LeuPro), and Hb Pak Num Po (1 codon 131/132 +T), and result in an -thalassemia phenotype.11-14     Genotypes of Hb H disease Top Introduction -Thalassemia mutations Genotypes of Hb H... Pathophysiology Clinical and laboratory... Alpha-thalassemia/mental... Acquired Hb H disease... Diagnosis Treatment Genetic counseling Summary References Deletional and nondeletional Hb H disease Hb H disease is commonly caused by a deletion removing both -globin genes on one chromosome 16, plus a deletion removing only a single -globin gene on the other chromosome 16 such as the (-3.7) or (-4.2) deletions. These are known as "deletional Hb H disease."11,15-33 In a smaller proportion of patients, Hb H disease is caused by a deletion removing both -globin genes on one chromosome 16, plus an +-thalassemia point mutation, or small insertion/deletion, involving either the 2- or 1-globin gene on the other chromosome 16. These are collectively labeled as the "nondeletional Hb H disease." Patients with nondeletional Hb H disease usually are more anemic, more symptomatic, more prone to have significant hepatosplenomegaly, and more likely to require transfusions.11,18,20,24,25,31,32 Rarely, homozygosity or compound heterozygosity of nondeletional +-thalassemia mutation(s) involving 2-globin gene on each of the 2 chromosomes 16, can lead to a phenotype similar to Hb H disease. They include initiation codon mutation (ATG>ACG), Hb Sallanches (codon 104 TGC>TAC or CysTyr), or polyadenylation signal mutation (AATAAA>AATAAG).25,29,34-37 Even in this small subset of patients, their phenotypes can vary from relatively mild to very severe, requiring regular transfusions. Population genetics Hb H disease is found in many parts of the world, including Southeast Asian, Middle Eastern, and Mediterranean populations. It is particularly prevalent in Southeast Asia and in southern China, because of high carrier frequencies of the (--SEA), and to a lesser extent, the (--FIL) types of -thalassemia deletions there.5,38,39 In Thailand with a population of 62 million people, it is estimated that 7000 infants with Hb H disease are born annually, and that there are 420 000 patients with Hb H disease in that country.40 The genotypes of 319 patients with Hb H disease from California, Hong Kong, and Ontario were reported during the past 2 years.31,33,41 These genotypes are summarized in Table 1 and serve to illustrate the heterogeneity of Hb H disease genotypes, especially in many multicultural communities in North America and elsewhere. Of those patients, 266 patients or 83% (95% confidence interval [CI], 79%-87%) have deletional Hb H disease. The most common genotype is (--SEA/-3.7) found in 175 patients (55%), followed by (--SEA/-4.2) 37 patients (12%), and (--FIL/ -3.7) 36 patients (11%). Fifty-three patients or 17% (95% CI, 13%-21%) have nondeletional Hb H disease. The most prevalent genotype among this subgroup is (--SEA/Constant Spring ) found in 31 patients (10%). In Thailand, nondeletional Hb H disease with Constant Spring is even more common, reportedly found in 40% to 50% of patients with Hb H disease.18 Among the 638 chromosomes examined in these 319 patients with Hb H disease, (--SEA) is found in 263 chromosomes (41%), (-3.7) in 224 chromosomes (35%), (-4.2) in 42 chromosomes (7%), (--FIL) in 38 chromosomes (6%), and (Constant Spring ) in 32 chromosomes (5%). The remaining 14 other mutations are found in 39 chromosomes (6%). In the Mediterranean region, the most common deletion removing both -globin genes in cis is the (--MED) deletion. Among 78 Cypriot patients with Hb H disease, 79% had the (--MED) deletion and 17% had the ()20.5 deletion.28     Pathophysiology Top Introduction -Thalassemia mutations Genotypes of Hb H... Pathophysiology Clinical and laboratory... Alpha-thalassemia/mental... Acquired Hb H disease... Diagnosis Treatment Genetic counseling Summary References In Hb H disease, there is a deficiency of -globin mRNA and -globin chains. These are reflected in the / globin mRNA ratio being below 0.5, and the / globin chain synthetic ratios ranging from 0.2 to 0.7.3,11,15,18 During fetal development, the excess -globin chains form 4 tetramers (Hb Bart). In adults, the excess -globin chains form 4 tetramers (Hb H). These homotetramers have high oxygen affinity, lack heme-heme interaction, and deliver only insignificant amounts of oxygen to tissues. Hb H (4) is relatively unstable and can be oxidized to form intracellular precipitates. If present within developing erythroblasts, these precipitates are thought to cause intramedullary early erythroid cell death and ineffective erythropoiesis. More often, these precipitates are formed in circulating erythrocytes with time and become attached to cell membrane. They cause local oxidative damage, membrane dysfunction, and shortened red cell survival.42 Hb H disease erythrocytes are rigid, and their membrane is more stable than normal.43 The membrane associated with Hb Constant Spring is even more rigid.44 These properties retard the passage of red blood cells through microvasculature and can promote erythrophagocytosis.45 There is evidence that pyrexia can enhance formation of intraerythrocytic Hb H inclusion bodies that might account for the acute hemolytic crisis and precipitous drop in hemoglobin associated with infections in some patients.11,46-48 Loss of normal membrane phospholipid asymmetry, particularly the exposure of phosphatidylserine on thalassemic cell surface, likely mediates intramedullary erythroblast apoptosis and engulfment of abnormal or aging circulating erythrocytes by macrophages.49-52 Erythrocyte membrane-associated immunoglobulin G (IgG) and complement components may also have similar roles in promoting erythrophagocytosis.45 It is generally accepted that hemolysis is the major cause of anemia in Hb H disease, although ineffective erythropoiesis also plays a pathogenetic role in this syndrome.15,51,53-56 In contrast, ineffective erythropoiesis is the dominant cause for the anemia in -thalassemia intermedia and major. Nondeletional Hb H disease is generally more severe.11,18,20,24,25,31,32 Given that 2-globin gene produces 2.5 times more -globin mRNA than the 1-globin gene, the combined -globin mRNA production from both -globin genes on a normal chromosome 16 could be assigned 3.5 "arbitrary units" for this discussion.8,45 In an -globin gene cluster harboring a point mutation inactivating 2-globin gene, the -globin mRNA production by the remaining and normal 1-globin gene is merely 1.0 "unit." However, with the single -globin gene deletion of the (-3.7) type as a result of a misalignment crossover event during meiosis, the -globin mRNA production by the remaining single hybrid -globin gene is 2.0 "units."45 This consideration provides at least partial explanation for the observation that patients with nondeletional Hb H disease such as (--SEA/Constant Spring) are more severely affected than those with deletional Hb H disease such as (--SEA/-3.7).31,45 In some cases, the nondeletional -globin gene mutation leads to highly unstable -globin chains or variant hemoglobin, such as Hb Quong Sze (2 codon 125 CTG>CCG or LeuPro).13 In addition to the more severe -globin chain deficiency, the intracellular aggregates of hyperunstable variant -globin chains or hemoglobins might also cause additional membrane damage and dysfunction. In one report, patients with nondeletional Hb H disease were found to have higher malonyldialdehyde levels, which is a secondary product of lipid peroxidation, and lower levels of vitamin E.57     Clinical and laboratory findings Top Introduction -Thalassemia mutations Genotypes of Hb H... Pathophysiology Clinical and laboratory... Alpha-thalassemia/mental... Acquired Hb H disease... Diagnosis Treatment Genetic counseling Summary References Hb H disease is generally thought to be a mild disorder. However, there is a marked phenotypic variability, ranging from asymptomatic, to need for periodic transfusions, to severe anemia with hemolysis and hepatosplenomegaly, and even to fatal hydrops fetalis syndrome in utero. Patients with identical -globin genotypes can have different phenotypes,30 suggesting that there are other yet undefined genetic and/or environmental factors that can affect phenotypic expression of Hb H disease.58,59 Anemia The hemoglobin level, mean erythrocyte corpuscular volume (MCV), and mean corpuscular hemoglobin (MCH) of patients with Hb H disease are tabulated in Table 2. There are significant variations in these values between individuals. For example, in one report, hemoglobin levels ranged between 70 and 129 g/L among 10 male patients and between 70 and 114 g/L among 41 female patients, all with deletional Hb H disease.33 MCV ranged from 51 to 73 fL. There are elevated reticulocyte counts (5%-10%), polychromasia, and moderate anisopoikilocytosis.60                                View this table: [in this window] [in a new window]   Table 2. Hemoglobin, MCV and MCH in patients with Hb H disease The MCV in nondeletional Hb H disease is higher than in deletional Hb H disease (Table 2). Anemia is more pronounced in nondeletional Hb H disease and so is reticulocytosis. This finding may partially account for the higher MCV. -Thalassemic erythrocytes are hyperhydrated, especially those inherited with Hb Constant Spring.43 In 15 patients with nondeletional Hb H disease/Hb Constant Spring, their Hb was 82 ± 19 g/L, and MCV was 76 ± 7 fL. In 5 other patients with nondeletional Hb H disease/Hb Quong Sze, their Hb was 86 ± 10 g/L, and MCV was 71 ± 7 fL. (V.C., unpublished observations, August 2002). It is postulated, although unproven, that the early closing of the K-Cl cotransporter in -thalassemic erythrocytes, in contrast to -thalassemic erythrocytes, prevents loss of K-Cl and water and leads to erythrocyte hyperhydration and higher MCV.45 There are occasions, such as increased hemolysis secondary to infections, fever, ingestion of oxidative compounds or drugs, aregenerative anemia as a result of Parvovirus B19 and other infections, hypersplenism, and pregnancy, when severe anemia may ensue and transfusions become necessary. In Thailand, 29% of 221 patients with deletional Hb H disease and 50% of 136 patients with nondeletional Hb H disease had been transfused.18 In Hong Kong, 46% of 114 patients with Hb H disease had been transfused, but only very few patients required regular transfusions.31 The microcytic and hypochromic anemia found in Hb H disease might lead to the erroneous diagnosis of iron deficiency anemia. On occasions, inappropriate iron supplement treatment or invasive investigations to rule out possible gastrointestinal bleeding are prescribed. Iron overload Iron overload as manifested by markedly elevated serum ferritin levels is present in 70% to 75% of adult patients with Hb H disease.61-63 Raised serum ferritin levels are correlated with increasing age but are unrelated to previous history of transfusions, iron supplement, or herbal medicine treatment.22,31 It is likely that iron absorption is increased in Hb H disease, secondary to enhanced erythropoiesis as a result of hemolysis and anemia.64 Excessive alcohol consumption is an additional risk factor.62 In Hong Kong, 60 patients underwent computed tomographic (CT) scan of liver, and 51 of them (85%) had a signal-intensity ratio of less than 1, indicative of iron overload.31,65 In others, liver biopsy revealed increased liver iron content and hepatic fibrosis and/or cirrhosis, without serologic evidence of either hepatitis B or C.22,31 In addition, 25 asymptomatic adult patients had cardiac echocardiography done, and all showed abnormal left ventricular diastolic function.31 There was a trend of increasing cardiac abnormality with increasing serum ferritin levels. Three patients had heart failure as a result of cardiac iron overload. Another patient developed hemosiderosis and diabetes mellitus.66 These findings underscore the importance of monitoring adult patients with Hb H disease for iron overload and to initiate iron chelation therapy when indicated. There are reports from the Mediterranean region that iron overload in Hb H disease is uncommon.11,30,67 The apparent discrepancy might be due to differences in other genetic or environmental factors. In Sardinia, some adult patients had serum ferritin levels at or close to 1000 µg/L.25 Long-term follow-up on those apparently unaffected patients should be informative. Hepatosplenomegaly Hepatomegaly was present in 70% of 502 patients in Thailand, 60% of 153 patients in Sardinia, and 14% of 88 patients in Taiwan.15,22,25 Jaundice was found in 25% of patients in Thailand, 20% to 30% in Sardinia, and 43% in Taiwan.18,22,25 Splenomegaly is also prevalent in Hb H disease, found in 79% of patients in Thailand, 60% in Sardinia, and 47% in Taiwan.15,22,25 In Hong Kong, a third of 27 patients with nondeletional Hb H disease had undergone splenectomy. In contrast, only 5% of 87 patients with deletional Hb H disease were splenectomized.31 Cholelithiasis Seventy-seven adult patients in Hong Kong had abdominal ultrasonography done. Twenty-six patients (34%) were found to have cholelithiasis, and 5 of them underwent cholecystectomy.31 Nineteen percent of 88 patients in Taiwan and 15% of 81 patients in Thailand had cholelithiasis.22,68 A promoter polymorphism in uridine diphosphate (UDP)-glucuronosyl-transferase, as in Gilbert disease, is a risk factor for cholelithiasis in hereditary spherocytosis, -thalassemia, and sickle cell disease.69-73 Whether this correlation also holds true for Hb H disease awaits confirmation. Growth and development in children Thirteen percent of children with Hb H disease in Hong Kong had a growth rate below the third percentile.31 In another report, 2 infants with Hb H disease were followed from birth to 6 months of age.74 At birth, the total hemoglobin was approximately 155 g/L, but only 110 to 120 g/L represented functional hemoglobins (Hb F and Hb A). The other 30 to 40 g/L were Hb Bart (4) and some Hb H (4), which have markedly impaired ability to deliver oxygen to tissues. At 1 to 2 months of age, the functional hemoglobin fractions fell to 70 g/L. By 3 months, these fractions had returned to 85 to 95 g/L. These anecdotal reports underscore the importance of a systematic investigation of the natural history of Hb H disease during early infancy and childhood.37 Pregnancy There is usually an increasing severity of anemia during pregnancy, possibly related to expansion of blood volume. Hb level may sometimes fall to 60 g/L or even less, necessitating the need for blood transfusion to maintain the health of the mother and the developing fetus.15,25,75,76 However, other women go through pregnancies without the need for transfusions.77 In 34 pregnancies among 29 Thai women, Hb fell to 71 ± 20 g/L during the second and third trimesters.75 Preeclampsia occurred in 18% of the cases, and 9% developed congestive heart failure. There was one case each of miscarriage and perinatal death and 3 cases of premature births. Galanello et al25 reported that there were 7 miscarriages (12%) among 58 pregnancies in 24 Italian women with Hb H disease. It is vitally important to carry out prospective and in-depth studies of pregnancies in women with Hb H disease to define the risks and criteria for treatment. Another important issue is related to testing the woman's partner and genetic counseling. This issue is discussed in more detail in "Genetic counseling." Hb H hydrops fetalis syndrome This devastating syndrome represents the most severe form of Hb H disease and was first described in detail in 1985.78 It is the subject of a recent review.79 The -globin genotypes of the affected fetuses consist of deletion of both -globin genes in cis or the complete --globin gene cluster on one chromosome 16 and a nondeletional mutation involving 2-globin gene on the other chromosome 16.79-81 These fetuses suffer from severe anemia and hypoxia in utero, with its sequelae such as edema, pericardial effusion, congenital anomalies, and even death. The pathophysiology of this serious inherited disorder is not well understood. One hypothesis is that the nondeletional -globin gene mutations, such as 2 codon 35 TCC>CCC or SerPro, codon 59 GGC>GAC or GlyAsp, or codon 66 CTG>CCG or LeuPro, result in highly unstable hemoglobin and severe anemia, akin to the dominant -thalassemia syndrome.79-82 With the mutation 2 codon 30 GAG, hydrops fetalis occurs only with the coinheritance of a deletion removing the complete --globin gene cluster.80 Other individuals who have inherited the same GAG mutation together with the Southeast Asian type of deletion removing both -globin genes in cis, but sparing the embryonic -globin gene, survive to adulthood, albeit with moderate to severe anemia (Hb, 72-105 g/L).31,80,83 More recently, another case of this severe syndrome was reported in a Turkish newborn, who died despite active resuscitation, soon after birth at the 30th week of gestation. This infant's -globin genotype was (--MED/AATAAA>AATAAG).84,142 Hb H disease in combination with other hemoglobinopathies Patients with both Hb H disease and heterozygosity for -globin variants such as Hb S, Hb C, or Hb E have hemoglobin levels similar to most patients with Hb H disease.85-89 The proportions of the variant hemoglobins are low (20%-25%), because of the lower affinity of the -globin chains for the variant -globin chains as compared with the normal -globin chains.90 There are exceptions, such as J-Iran (codon 77 CAC>GAC or HisAsp) that is a negatively charged variant -globin chain.91 With Hb H disease, the proportion of this variant Hb increases to 65%.91 These patients with variant -globin chains as well as those with -thalassemia trait have low Hb H levels and scanty Hb H inclusion bodies. Hb E is very common in Southeast Asia. In Thailand, interactions of Hb H disease with Hb E and/or -thalassemia give rise to many different complex genotypes. They are broadly known as AE-Bart disease (Hb H disease and heterozygosity for Hb E), and EF-Bart disease (Hb H disease and homozygosity for Hb E or Hb E/-thalassemia).88,89 They present with thalassemia intermedia phenotype with moderate to severe anemia and with decreased or no Hb H and inclusion bodies detected. Patients who have Hb H disease together with heterozygosity for New York (codon 113 GTG>GAG or ValGlu) have severe anemia (Hb between 34 and 68 g/L) and hepatosplenomegaly.92 The variant New York has higher affinity for the -globin chains to form Hb New York that is an unstable hemoglobin. This worsens the deficiency of -globin chains already present in Hb H disease and causes even more severe anemia. Coinheritance of Hb H disease and several other uncommon variant -globin chains has been described, such as Hb J Bangkok (codon 56 GGC>GAC or GlyAsp), Hb Pyrgos (codon 83 GGC>GAC or GlyAsp), and Hb Hope (codon 136 GGT>GAT or GlyAsp).93-95 Coinheritance of Hb H disease and -thalassemia heterozygosity leads to anemia usually more severe than -thalassemia heterozygote alone, but less than common Hb H disease.96-98 However, there are exceptions and some patients require transfusions.28,98 They have marked microcytosis and hypochromia, but low or absent Hb H and Hb H inclusion bodies. Hb A2 levels are elevated, as in most other -thalassemia heterozygotes.96-98 Other findings The following findings associated with Hb H disease have been reported: dysmorphic facial features, skeletal changes, retinopathy, extramedullary hematopoietic tumors, risk of thromboembolic disorders, and leg ulcers.3,99-102 Erythrocyte glucose-6-phosphate dehydrogenase (G6PD) deficiency is prevalent in the same populations in whom thalassemias are prevalent. Therefore, coinheritance of both Hb H disease and G6PD deficiency is to be expected.47,103 Recently in Hong Kong, a newborn was found to have Hb H disease (--SEA/Constant Spring) and G6PD deficiency (0.1 U/g Hb in cord blood). At birth, the infant was anemic with Hb of 125 g/L and had hepatosplenomegaly. At 1 year of age, his Hb fell to 42 g/L soon after an episode of infection and fever (E. S. K. Ma, unpublished observations, August 2002).     Alpha-thalassemia/mental retardation (ATR) syndromes Top Introduction -Thalassemia mutations Genotypes of Hb H... Pathophysiology Clinical and laboratory... Alpha-thalassemia/mental... Acquired Hb H disease... Diagnosis Treatment Genetic counseling Summary References ATR-16 syndrome The affected children have chromosomal rearrangements that delete as much as 1 to 2 Mb of chromosome 16 short-arm (16p) telomere, including the --globin gene complex, resulting in monosomy for the 16p telomere, and -thalassemia phenotype.104 In some, the chromosomal abnormalities can be visualized by cytogenetic analysis or fluorescent in situ hybridization (FISH). In most cases, one parent carried a balanced translocation that the child inherited in an unbalanced fashion. In others, the abnormality arose as de novo events. If the affected child also inherited a common single -globin gene deletion from the other parent, the child would have Hb H disease.105 It is thought that mental retardation and other congenital anomalies observed in this syndrome are caused by the deletion of dosage-sensitive genes on one 16p telomere and other concomitant chromosomal abnormalities. Children with deletions of up to 350 kb in length from one 16p telomere, including the complete --globin gene complex, have -thalassemia trait but are developmentally normal.106 It is critical for understanding the genetic basis of mental retardation to identify these genes on 16p telomere that can affect severe cognitive and developmental abnormalities when only one copy is deleted.105,107 ATR-X syndrome This syndrome is an X-linked disorder, caused by mutations of the ATRX gene located on chromosome Xq13.3.108 It is more common than the ATR-16 syndrome. The affected males usually have very severe intellectual and physical handicaps and many other congenital anomalies. They often have characteristic facial features. Genital abnormalities, such as ambiguous genitalia, and skeletal deformities are present in 90% of these patients.109 They present with an -thalassemia phenotype but with considerable variations with Hb H inclusion bodies found in none to up to 32% of circulating erythrocytes.105 The functions of ATRX protein in vivo are not yet understood and are under active investigation.110 It contains motifs that have been implicated in the regulation of transcription mediated by chromatin modification, protein-protein interaction, adenosine triphosphatase (ATPase), and helicase activities and that affect genomic methylation pattern.111,112 The highly variable phenotypes in patients suggest that ATRX interacts with other genetic factors to bring about normal expression of many genes of developmental importance, including the - but not the -globin genes.105     Acquired Hb H disease in myeloproliferative disorders Top Introduction -Thalassemia mutations Genotypes of Hb H... Pathophysiology Clinical and laboratory... Alpha-thalassemia/mental... Acquired Hb H disease... Diagnosis Treatment Genetic counseling Summary References This syndrome has been described mostly in elderly men who have primary marrow disorders such as erythroleukemia, myelodysplasia, refractory anemia with excessive blasts, acute leukemia, and so forth. Its molecular pathology has not been defined, although it is conceivable that the down-regulation of -globin gene expression in these patients is the result of somatic mutation(s) in transcription factor(s). This and the relatively rare ATR syndromes provide important insight into the biology of -globin gene regulation and expression, as well as other developmental pathways. They are the subjects of 2 recent reviews3,105 and are beyond the scope of the present manuscript.     Diagnosis Top Introduction -Thalassemia mutations Genotypes of Hb H... Pathophysiology Clinical and laboratory... Alpha-thalassemia/mental... Acquired Hb H disease... Diagnosis Treatment Genetic counseling Summary References Hb H disease is characterized by moderate hypochromic and microcytic anemia (see "Anemia"). Formation of Hb H (4) precipitates within red cells (Hb H inclusion bodies) can be induced by incubation with mild oxidants such as Brilliant Cresyl Blue.113 These inclusion bodies are numerous and can easily be seen by light microscopy in most circulating erythrocytes. In addition, Hb H ranging between 5% and 30% can be detected by hemoglobin electrophoresis, isoelectric focusing (IEF), or high-performance liquid chromatography (HPLC).60 Hb H levels are usually higher in nondeletional Hb H disease than in deletional Hb H disease. It should be noted that some commercial electrophoretic methods are incapable of detecting Hb H.114 Hb A2 level is usually down in the 1.0% to 2.0% range.60 Patients who have Hb H disease and concomitant heterozygous -hemoglobinopathies, such as Hb S, Hb C, Hb E, or -thalassemia, have low or absent Hb H (4) and many fewer Hb H inclusion bodies.85-89,96-98 These hematologic findings may confound the diagnosis of the underlying Hb H disease. Correct DNA-based genotyping is necessary for genetic counseling and prenatal diagnosis. Southern blotting is often used for diagnosing deletional mutations. More recently, Gap-polymerase chain reaction (PCR) methods have been developed for many of the common deletions.115-117 In large deletions that remove the complete --globin gene cluster, the diagnosis is more difficult and often depends on family studies and Southern blotting analysis using probes distal to the deletional breakpoints.118,119 For point mutations, or small deletion/insertion mutations, the diagnosis is often based on direct nucleotide sequencing of the PCR-amplified product of either 2- or 1-globin gene.79-81,83,84 Reverse dot-blot by hybridization with allele specific oligonucleotide probes and multiplex ARMS (PCR-based amplification refractory mutation system) assays have been developed for rapid diagnosis of several +-thalassemia point mutations.120,121 Hb Bart (4) is a fast-moving hemoglobin that can be determined by electrophoresis, IEF, or HPLC. Newborns who have inherited Hb H disease have 20% to 40% of Hb Bart at birth.60 Universal newborn screening for Hb H disease was implemented in 1996 in California, based on an elevated level of a fast-moving peak on HPLC of hemolysates eluted from newborn blood spots impregnated on filter papers.41 Of 101 newborns found to have 25% or more of this peak, 89 were confirmed by DNA diagnostics to have Hb H disease. Table 3 shows that in California, there are many more newborns with Hb H disease than with other commonly screened for inherited metabolic disorders such as phenylketonuria and galactosemia.                                View this table: [in this window] [in a new window]   Table 3. Number of newborns diagnosed annually through the universal newborn screening program in California41 The (--SEA) type of 0-thalassemia deletion is very common in Southeast Asia. An enzyme-linked immunosorbent assay (ELISA) to detect embryonic -globin chains in peripheral blood erythrocytes was reported to be a simple, rapid, and reliable screening test to identify adult carriers of the (--SEA) 0-thalassemia deletion.122-125 This test should help to identify couples at risk of conceiving fetuses with Hb H disease and also homozygous 0-thalassemia hydrops fetalis syndrome.     Treatment Top Introduction -Thalassemia mutations Genotypes of Hb H...